$BIIB Headlines Bed Bath & Beyond shares sink
Post# of 144507
Posted On: 01/13/2015 1:10:37 PM
$BIIB Headlines
Bed Bath & Beyond shares sink as sales miss consensus 6:48 p.m. Jan. 8, 2015 - MarketWatch
Drug trials, upgrades boost health-care sector 11:57 a.m. Jan. 8, 2015 - Russ Britt
Biogen rises 6.2% after strong study results 7:56 a.m. Jan. 8, 2015 - MarketWatch
Biogen Idec shares up 5% in premarket trade 7:43 a.m. Jan. 8, 2015 - Ciara Linnane
Why speculators see opportunity in younger, cyclical stocks 2:50 p.m. Dec. 26, 2014 - The Trading Deck
Cal-Maine Foods shares fall on earnings miss 4:41 p.m. Dec. 23, 2014 - Barbara Kollmeyer
Small caps rise within view of uncharted territory 10:26 a.m. Dec. 22, 2014 - Michael Ashbaugh
S&P 500 back for another crack at major support 10:14 a.m. Dec. 12, 2014 - Michael Ashbaugh
Biogen's Alzheimer's surprise 11:24 a.m. Dec. 9, 2014 - The Trading Deck
U.S. stocks post biggest gain in a month 5:06 p.m. Dec. 2, 2014 - Barbara Kollmeyer
Bob Evans earnings in spotlight after hours 3:41 p.m. Dec. 2, 2014 - Sue Chang
Biogen Alzheimer’s drug skips to Phase 3 testing 3:22 p.m. Dec. 2, 2014 - Russ Britt
Biogen Idec jumps 7%, faring best in S&P 500 9:33 a.m. Dec. 2, 2014 - Victor Reklaitis
Biogen's stock surges on upbeat outlook for Alzheimer's treatment 9:27 a.m. Dec. 2, 2014 - Tomi Kilgore
Biogen planning 'aggressively' to start Phase 3 study for Alzheimer's treatment 9:18 a.m. Dec. 2, 2014 - Tomi Kilgore
Biogen's stock rallies 5% in premarket trade 8:54 a.m. Dec. 2, 2014 - Tomi Kilgore
Is the next Cisco out there? 3:23 p.m. Nov. 25, 2014 - The Trading Deck
AT&T, Yelp shares decline after earnings 5:48 p.m. Oct. 22, 2014 - Sue Chang
U.S. stocks wither; S&P 500 ends 4-day win steak 4:39 p.m. Oct. 22, 2014 - Carla Mozee
Updates, advisories and surprises 4:31 p.m. Oct. 22, 2014 - MarketWatch
Veteran Analyst’s Top Health-Care Picks for 2015 10:32 a.m. Today - Barrons.com
Short Interest in Biotechs Signals Optimism 7:58 a.m. Today - 247WallSt.com
A Look At 3 Biotech Stocks With Upside Potential 3:25 p.m. Jan. 12, 2015 - benzinga.com
Stocks Sink as Wall Street 'Fixates' on Stabilization in Oil Prices 2:38 p.m. Jan. 12, 2015 - TheStreet.com
Regeneron Can Generate 25% Upside for Investors 1:44 p.m. Jan. 12, 2015 - Barrons.com
Stocks Are Falling as Oil Prices Crumble to New 5-Year Low 11:13 a.m. Jan. 12, 2015 - TheStreet.com
Stock Futures Recover From Friday’s Jobs Growth Jitters 9:14 a.m. Jan. 12, 2015 - TheStreet.com
Wall Street Breakfast: Week Begins With Healthcare Deals 6:31 a.m. Jan. 12, 2015 - Seeking Alpha
Biogen buys U.K.-based pain med developer 10:14 p.m. Jan. 11, 2015 - Seeking Alpha
Biogen Reveals Positive Data from Acute Optic Neuritis Study - Analyst Blog 5:35 p.m. Jan. 9, 2015 - Zacks.com
'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab 2:56 p.m. Jan. 9, 2015 - TheStreet.com
Isis Pharmaceuticals Improves 2014 Outlook, Shares Up - Analyst Blog 10:40 a.m. Jan. 9, 2015 - Zacks.com
Biogen’s MS Drug Shows Promise Despite Study Failures 1:13 p.m. Jan. 8, 2015 - The Wall Street Journal Interactive Edition
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1 1:09 p.m. Jan. 8, 2015 - TheStreet.com
Phase 2 results mixed for Biogen AON drug candidate 11:10 a.m. Jan. 8, 2015 - Seeking Alpha
Biogen Nerve-Repair Drug Yields Mixed Results 10:45 a.m. Jan. 8, 2015 - Investors Business Daily
Biogen Idec (BIIB): Today's Weak On High Volume Stock 10:19 a.m. Jan. 8, 2015 - TheStreet.com
Today's Market: Stocks Moving On News 9:40 a.m. Jan. 8, 2015 - Seeking Alpha
Biogen's Nerve Repair Drug Yields Mixed Results in Key Eye Trial 8:34 a.m. Jan. 8, 2015 - TheStreet.com
Eight Biotechs to Outperform the Market 8:24 a.m. Jan. 8, 2015 - Barrons.com
3D Bioprinting Pioneers RBCC and n3D Biosciences Network With Top Biotechnology Investors This Week at Biotech Showcase 2015 in San Francisco 5:00 a.m. Today - BusinessWire - BZX
Biogen Idec to Expand Neuropathic Pain Portfolio with the Acquisition of Convergence Pharmaceuticals 8:00 p.m. Jan. 11, 2015 - BusinessWire - BZX
Kite Pharma Expands Senior Management Team With Appointment of Claudine Prowse, Ph.D., as SVP, Corporate Communications and Investor Relations 8:01 a.m. Jan. 9, 2015 - GlobeNewswire
Incyte Board Appoints Two New Directors 8:00 a.m. Jan. 9, 2015 - BusinessWire - BZX
Biogen Idec and Columbia University Medical Center to Conduct Collaborative Genetics Research 8:00 a.m. Jan. 9, 2015 - BusinessWire - BZX
Biogen Idec Reports Positive Top-Line Results from Phase 2 Anti-LINGO-1 Trial in People with Acute Optic Neuritis 7:30 a.m. Jan. 8, 2015 - BusinessWire - BZX
Global Psoriasis Therapeutics Market 2015-2019 2:12 p.m. Jan. 7, 2015 - PR Newswire - PRF
Biogen Idec to Report Fourth Quarter and Year End 2014 Financial Results on January 28, 2015 4:01 p.m. Dec. 23, 2014 - BusinessWire - BZX
Biogen Idec to Present at the 33rd Annual J.P. Morgan Healthcare Conference 4:01 p.m. Dec. 22, 2014 - BusinessWire - BZX
Alnylam Elects Michael W. Bonney to Its Board of Directors 8:02 a.m. Dec. 18, 2014 - BusinessWire - BZX
Biotech Equities Update - Biogen Idec, ACADIA Pharma, Halozyme Therapeutics, Neurocrine Biosciences, and Bluebird Bio 8:50 a.m. Dec. 12, 2014 - PR Newswire - PRF
Small Cap Profiles: OPXA, NEWC, TRNS, MLER 10:35 a.m. Dec. 11, 2014 - ACCESSWIRE
Biogen Idec and Gilead Sciences Join the National Pharmaceutical Council 9:15 a.m. Dec. 9, 2014 - PR Newswire - PRF
Bertilimumab Chosen as a Top Autoimmune/Anti-Inflammatory Projects to Watch 7:30 a.m. Dec. 1, 2014 - PR Newswire - PRF
U.S. Claims Data Show That Biogen Idec's Tecfidera Captured Nearly Half of Second-Line Share Among Newly Diagnosed Multiple Sclerosis Patients 1:30 p.m. Nov. 24, 2014 - PR Newswire - PRF
Sobi exercises opt-in right for Elocta(TM) 2:01 a.m. Nov. 21, 2014 - Thomson Reuters ONE
Vital Therapies Expands Management Team 8:01 a.m. Nov. 20, 2014 - GlobeNewswire
Biogen Idec to Present at the 2014 Deutsche Bank BioFEST Conference 4:01 p.m. Nov. 19, 2014 - BusinessWire - BZX
Forward Pharma Sues Biogen Idec Over Tecfidera(R) Sales in Germany 8:30 a.m. Nov. 18, 2014 - GlobeNewswire
Study Results, Financial Results, Regulatory Updates, and Upcoming Conference - Research Reports on Medtronic, Zoetis, Biogen, Tenet Health and Aetna 8:55 a.m. Nov. 7, 2014 - PR Newswire - PRF
Bed Bath & Beyond shares sink as sales miss consensus 6:48 p.m. Jan. 8, 2015 - MarketWatch
Drug trials, upgrades boost health-care sector 11:57 a.m. Jan. 8, 2015 - Russ Britt
Biogen rises 6.2% after strong study results 7:56 a.m. Jan. 8, 2015 - MarketWatch
Biogen Idec shares up 5% in premarket trade 7:43 a.m. Jan. 8, 2015 - Ciara Linnane
Why speculators see opportunity in younger, cyclical stocks 2:50 p.m. Dec. 26, 2014 - The Trading Deck
Cal-Maine Foods shares fall on earnings miss 4:41 p.m. Dec. 23, 2014 - Barbara Kollmeyer
Small caps rise within view of uncharted territory 10:26 a.m. Dec. 22, 2014 - Michael Ashbaugh
S&P 500 back for another crack at major support 10:14 a.m. Dec. 12, 2014 - Michael Ashbaugh
Biogen's Alzheimer's surprise 11:24 a.m. Dec. 9, 2014 - The Trading Deck
U.S. stocks post biggest gain in a month 5:06 p.m. Dec. 2, 2014 - Barbara Kollmeyer
Bob Evans earnings in spotlight after hours 3:41 p.m. Dec. 2, 2014 - Sue Chang
Biogen Alzheimer’s drug skips to Phase 3 testing 3:22 p.m. Dec. 2, 2014 - Russ Britt
Biogen Idec jumps 7%, faring best in S&P 500 9:33 a.m. Dec. 2, 2014 - Victor Reklaitis
Biogen's stock surges on upbeat outlook for Alzheimer's treatment 9:27 a.m. Dec. 2, 2014 - Tomi Kilgore
Biogen planning 'aggressively' to start Phase 3 study for Alzheimer's treatment 9:18 a.m. Dec. 2, 2014 - Tomi Kilgore
Biogen's stock rallies 5% in premarket trade 8:54 a.m. Dec. 2, 2014 - Tomi Kilgore
Is the next Cisco out there? 3:23 p.m. Nov. 25, 2014 - The Trading Deck
AT&T, Yelp shares decline after earnings 5:48 p.m. Oct. 22, 2014 - Sue Chang
U.S. stocks wither; S&P 500 ends 4-day win steak 4:39 p.m. Oct. 22, 2014 - Carla Mozee
Updates, advisories and surprises 4:31 p.m. Oct. 22, 2014 - MarketWatch
Veteran Analyst’s Top Health-Care Picks for 2015 10:32 a.m. Today - Barrons.com
Short Interest in Biotechs Signals Optimism 7:58 a.m. Today - 247WallSt.com
A Look At 3 Biotech Stocks With Upside Potential 3:25 p.m. Jan. 12, 2015 - benzinga.com
Stocks Sink as Wall Street 'Fixates' on Stabilization in Oil Prices 2:38 p.m. Jan. 12, 2015 - TheStreet.com
Regeneron Can Generate 25% Upside for Investors 1:44 p.m. Jan. 12, 2015 - Barrons.com
Stocks Are Falling as Oil Prices Crumble to New 5-Year Low 11:13 a.m. Jan. 12, 2015 - TheStreet.com
Stock Futures Recover From Friday’s Jobs Growth Jitters 9:14 a.m. Jan. 12, 2015 - TheStreet.com
Wall Street Breakfast: Week Begins With Healthcare Deals 6:31 a.m. Jan. 12, 2015 - Seeking Alpha
Biogen buys U.K.-based pain med developer 10:14 p.m. Jan. 11, 2015 - Seeking Alpha
Biogen Reveals Positive Data from Acute Optic Neuritis Study - Analyst Blog 5:35 p.m. Jan. 9, 2015 - Zacks.com
'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab 2:56 p.m. Jan. 9, 2015 - TheStreet.com
Isis Pharmaceuticals Improves 2014 Outlook, Shares Up - Analyst Blog 10:40 a.m. Jan. 9, 2015 - Zacks.com
Biogen’s MS Drug Shows Promise Despite Study Failures 1:13 p.m. Jan. 8, 2015 - The Wall Street Journal Interactive Edition
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1 1:09 p.m. Jan. 8, 2015 - TheStreet.com
Phase 2 results mixed for Biogen AON drug candidate 11:10 a.m. Jan. 8, 2015 - Seeking Alpha
Biogen Nerve-Repair Drug Yields Mixed Results 10:45 a.m. Jan. 8, 2015 - Investors Business Daily
Biogen Idec (BIIB): Today's Weak On High Volume Stock 10:19 a.m. Jan. 8, 2015 - TheStreet.com
Today's Market: Stocks Moving On News 9:40 a.m. Jan. 8, 2015 - Seeking Alpha
Biogen's Nerve Repair Drug Yields Mixed Results in Key Eye Trial 8:34 a.m. Jan. 8, 2015 - TheStreet.com
Eight Biotechs to Outperform the Market 8:24 a.m. Jan. 8, 2015 - Barrons.com
3D Bioprinting Pioneers RBCC and n3D Biosciences Network With Top Biotechnology Investors This Week at Biotech Showcase 2015 in San Francisco 5:00 a.m. Today - BusinessWire - BZX
Biogen Idec to Expand Neuropathic Pain Portfolio with the Acquisition of Convergence Pharmaceuticals 8:00 p.m. Jan. 11, 2015 - BusinessWire - BZX
Kite Pharma Expands Senior Management Team With Appointment of Claudine Prowse, Ph.D., as SVP, Corporate Communications and Investor Relations 8:01 a.m. Jan. 9, 2015 - GlobeNewswire
Incyte Board Appoints Two New Directors 8:00 a.m. Jan. 9, 2015 - BusinessWire - BZX
Biogen Idec and Columbia University Medical Center to Conduct Collaborative Genetics Research 8:00 a.m. Jan. 9, 2015 - BusinessWire - BZX
Biogen Idec Reports Positive Top-Line Results from Phase 2 Anti-LINGO-1 Trial in People with Acute Optic Neuritis 7:30 a.m. Jan. 8, 2015 - BusinessWire - BZX
Global Psoriasis Therapeutics Market 2015-2019 2:12 p.m. Jan. 7, 2015 - PR Newswire - PRF
Biogen Idec to Report Fourth Quarter and Year End 2014 Financial Results on January 28, 2015 4:01 p.m. Dec. 23, 2014 - BusinessWire - BZX
Biogen Idec to Present at the 33rd Annual J.P. Morgan Healthcare Conference 4:01 p.m. Dec. 22, 2014 - BusinessWire - BZX
Alnylam Elects Michael W. Bonney to Its Board of Directors 8:02 a.m. Dec. 18, 2014 - BusinessWire - BZX
Biotech Equities Update - Biogen Idec, ACADIA Pharma, Halozyme Therapeutics, Neurocrine Biosciences, and Bluebird Bio 8:50 a.m. Dec. 12, 2014 - PR Newswire - PRF
Small Cap Profiles: OPXA, NEWC, TRNS, MLER 10:35 a.m. Dec. 11, 2014 - ACCESSWIRE
Biogen Idec and Gilead Sciences Join the National Pharmaceutical Council 9:15 a.m. Dec. 9, 2014 - PR Newswire - PRF
Bertilimumab Chosen as a Top Autoimmune/Anti-Inflammatory Projects to Watch 7:30 a.m. Dec. 1, 2014 - PR Newswire - PRF
U.S. Claims Data Show That Biogen Idec's Tecfidera Captured Nearly Half of Second-Line Share Among Newly Diagnosed Multiple Sclerosis Patients 1:30 p.m. Nov. 24, 2014 - PR Newswire - PRF
Sobi exercises opt-in right for Elocta(TM) 2:01 a.m. Nov. 21, 2014 - Thomson Reuters ONE
Vital Therapies Expands Management Team 8:01 a.m. Nov. 20, 2014 - GlobeNewswire
Biogen Idec to Present at the 2014 Deutsche Bank BioFEST Conference 4:01 p.m. Nov. 19, 2014 - BusinessWire - BZX
Forward Pharma Sues Biogen Idec Over Tecfidera(R) Sales in Germany 8:30 a.m. Nov. 18, 2014 - GlobeNewswire
Study Results, Financial Results, Regulatory Updates, and Upcoming Conference - Research Reports on Medtronic, Zoetis, Biogen, Tenet Health and Aetna 8:55 a.m. Nov. 7, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼